Skip to main content
Appeal outcomes · California IMR · Diag Imag & Screen

Allergy Testing denials: 10.0% overturned by independent reviewers

In 60 California IMR decisions from 2004 to 2024, reviewers overturned the plan 6 times (10.0%). In the last five years: 0.0% of 20. Denials reach IMR only when a member appeals all the way; read the caveats below before generalising.

By diagnosis

Diagnosis categoryDecisionsOverturnedLast 5 years
Pediatrics230.0%0.0% of 16
Digestive System/ GI110.0%
Respiratory System616.7%0.0% of 2
Skin Disorders650.0%0.0% of 1

By year (last five)

YearDecisionsOverturned
2021100.0%
202230.0%
202340.0%
202430.0%

What the findings mention

What the findings mentionDecisionsOverturnedAll decisions here
Published evidence citedThe findings refer to peer-reviewed or published evidence.254.0%10.0%
Records did not supportThe findings say the documentation did not show what was needed (usually an upheld denial).812.5%10.0%
Guidelines or criteria citedThe findings cite guidelines, criteria or a standard of care.40.0%10.0%

Keyword matches on the reviewer’s findings, not causes. A tag that appears mostly in overturned decisions is worth documenting in an appeal; it is not a guarantee.

From recent overturned decisions

Nature of Statutory Criteria/Case Summary: The patient has requested authorization and coverage for allergy testing. Given the history and physical examination findings noted in the medical records, the likely diagnosis for this patient’s skin condition is atopic dermatitis (AD). There is adequate evidence in the medical literature to support testing for foods to help determine the aggravators of the underlying …

Reviewer findings, overturned decision · Medical Necessity · 2020 · Source: California DMHC IMR determinations (CHHS Open Data), reference MN20-33888

An enrollee has requested authorization and coverage for a lymphocyte transformation test. Metal hypersensitivity is a possible cause for arthrofibrosis and associated pain in patients after joint arthroplasty. For this patient, the requested lymphocyte transformation test is appropriate because it will help guide treatment. Researchers found that lymphocyte transformation testing shows promise in diagnosing metal allergy and components of bone …

Reviewer findings, overturned decision · Experimental/Investigational · 2020 · Source: California DMHC IMR determinations (CHHS Open Data), reference EI20-32906

Nature of Statutory Criteria/Case Summary: An enrollee has requested reimbursement for a breathing test. While the measurement of fractional exhaled nitric oxide (FENO) is not utilized by itself in the evaluation and management of asthma, it has been demonstrated to be of value in conjunction with clinical parameters. Its use is associated with significantly lower asthma exacerbation rates compared with …

Reviewer findings, overturned decision · Experimental/Investigational · 2018 · Source: California DMHC IMR determinations (CHHS Open Data), reference EI18-29496
Read these numbers carefully
  • California only: these are decisions by independent reviewers under California's IMR program (plans regulated by the Department of Managed Health Care). Other states and self-funded employer plans use different reviewers and rules.
  • Selection: only denials that a member took all the way to IMR appear. Most denials are never appealed, and the ones that reach an external reviewer are not a random sample.
  • Overturned means the reviewer disagreed with the plan; it does not mean the treatment worked or that a similar request will be approved.
  • Argument tags are keyword matches on the reviewer's findings. They describe what the findings mention, not why the case was decided.
  • Categories are DMHC's own labels (treatment sub-category and diagnosis category); 'Other' is a catch-all and is excluded from rankings.

Source: California Department of Managed Health Care, Independent Medical Review (IMR) Determinations, Trend (CHHS Open Data). Public California government data; Apellica's aggregates and tags are CC BY 4.0.

Questions

How often were Allergy Testing denials overturned?

In 60 California IMR decisions from 2004 to 2024, reviewers overturned the plan 6 times (10.0%). In the last five years: 0.0% of 20.

What did the reviewers' findings mention in overturned cases?

The table on this page counts keyword matches in the findings: prior therapies tried, contraindications, guidelines cited, published evidence, whether the records supported the request. They describe what the findings say, not why the case was decided.

Does a California IMR result apply to my plan?

Only California plans regulated by the Department of Managed Health Care go to IMR. Other states and self-funded employer plans use different reviewers, but the reasoning is the same kind: criteria, documentation and alternatives. Use the findings as a guide to what to document.

Ask an AI assistant about this page:ChatGPTPerplexityGoogle AIClaudeOpens in a new tab with a question about this page. Nothing about you is sent.

Related: California appeal rights · California external-review reversal rate · The levers library · CSV

Denied for this?

Independent reviewers reverse plans when the record answers the criteria. Upload the denial letter; a senior reviewer reads it within 24 hours and tells you in writing whether it can be appealed and how. $0 upfront, 10% of what is recovered, nothing if we do not recover. Not a law firm.